Sarepta Therapeutics (SRPT) Net Margin (2010 - 2026)
Sarepta Therapeutics (SRPT) posted quarterly Net Margin of 45.29% for Q1 2026, up 38093.0% year-over-year from N/an in Q1 2025, and up 170.91% quarter-over-quarter from 63.87% in Q4 2025.
Sarepta Therapeutics (SRPT) Net Margin (2010 - 2026) Analysis & Trends
Sarepta Therapeutics' Net Margin history runs 15 years deep, the most recent figure standing at 45.29% for Q1 2026.
- In Q1 2026, Net Margin rose 38093.0% year-over-year to 45.29%; the TTM figure through Mar 2026 stood at 2.98% (up 1829.0% YoY), while the FY2025 annual figure was 38.27%, down 5064.0% from the prior year.
- Net Margin for Q1 2026 stood at 45.29%, up from 63.87% in the prior quarter.
- The five-year high for Net Margin was 45.29% in Q1 2026, with the low at 335.64% in Q1 2025.
- The 5-year median for Net Margin is 9.16% (2023), against an average of 47.39%.
- The sharpest annual moves came in 2025 and 2026: Net Margin sank 34448 bps in 2025, then surged 38093 bps in 2026.
- Sarepta Therapeutics' Net Margin stood at 38.02% in 2022, then slumped by 89 bps to 4.22% in 2023, then jumped by 472 bps to 24.12% in 2024, then sank by 365 bps to 63.87% in 2025, then soared by 171 bps to 45.29% in 2026.
- Business Quant data shows SRPT's Net Margin at 45.29% in Q1 2026, 63.87% in Q4 2025, and 45.06% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 32.99% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 30.23% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 30.33% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.90% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 30.98% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 12.09% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 12.74% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -3.12% |
| 10 | Sarepta Therapeutics | 1.91 Bn | 1.12 Bn | 251.87 Mn | -1.22% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.22% |
| Mar 31, 2026 | 45.29% |
| Dec 31, 2025 | -63.87% |
| Sep 30, 2025 | -45.06% |
| Jun 30, 2025 | 32.23% |
| Mar 31, 2025 | -335.64% |
| Dec 31, 2024 | 24.12% |
| Sep 30, 2024 | 7.19% |
| Jun 30, 2024 | 1.87% |
| Mar 31, 2024 | 8.84% |
| Dec 31, 2023 | 4.22% |
| Sep 30, 2023 | -13.23% |
| Jun 30, 2023 | -9.16% |
| Mar 31, 2023 | -223.23% |
| Dec 31, 2022 | 38.02% |
| Sep 30, 2022 | -111.93% |
| Jun 30, 2022 | -109.58% |
| Mar 31, 2022 | -55.63% |
| Dec 31, 2021 | -68.42% |
| Sep 30, 2021 | -214.02% |